Yahoo Poland Wyszukiwanie w Internecie

Search results

1. www.pfizer.com › pfizer-biontech-covid-19-vaccine-comirnatyr-receives-fullPfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S....

   www.pfizer.com › pfizer-biontech-covid-19-vaccine-comirnatyr-receives-full

   • Zapisane w pamięci cache

   11 gru 2020 · COMIRNATY ® (COVID-19 Vaccine, mRNA) is an FDA-approved COVID-19 vaccine made by Pfizer for BioNTech. It is approved as a 2-dose series for prevention of COVID-19 in individuals 16 years of age and older; It is also authorized under Emergency Use Authorization (EUA) to be administered for emergency use to:

   • View PDF

     The Pfizer-BioNTech COVID-19 Vaccine has received EUA from...

   • Vaccines Manufacturing B-roll Video

     This information—including product information—is intended...

2. www.pfizer.com › pfizer-and-biontech-announce-omicron-adapted-covid-19Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine ...

   www.pfizer.com › pfizer-and-biontech-announce-omicron-adapted-covid-19

   • Zapisane w pamięci cache

   25 cze 2022 · Omicron-adapted monovalent candidate given as a fourth booster dose elicited a 13.5 and 19.6-fold increase in neutralizing geometric titers against Omicron BA.1 at 30 µg and 60 µg dose levels; bivalent vaccine candidate exhibited a 9.1 and 10.9-fold increase against Omicron.

3. www.ema.europa.eu › en › newsFirst adapted COVID-19 booster vaccines recommended for approval...

   www.ema.europa.eu › en › news

   • Zapisane w pamięci cache

   1 wrz 2022 · EMA’s human medicines committee (CHMP) has recommended authorising two vaccines adapted to provide broader protection against COVID-19. Comirnaty Original/Omicron BA.1 and Spikevax bivalent Original/Omicron BA.1 are for use in people aged 12 years and above who have received at least primary vaccination against COVID-19.

4. www.ema.europa.eu › en › newsEMA recommends authorisation of booster doses of Comirnaty from...

   www.ema.europa.eu › en › news

   • Zapisane w pamięci cache

   24 lut 2022 · EMA’s human medicines committee (CHMP) has recommended that a booster dose of the COVID-19 vaccine Comirnaty may be given where appropriate to adolescents from 12 years of age.

5. www.ema.europa.eu › en › newsComirnaty and Spikevax: EMA recommendations on extra doses and...

   www.ema.europa.eu › en › news

   • Zapisane w pamięci cache

   4 paź 2021 · EMA’s human medicines committee (CHMP) has concluded that an extra dose of the COVID-19 vaccines Comirnaty (BioNTech/Pfizer) and Spikevax (Moderna) may be given to people with severely weakened immune systems, at least 28 days after their second dose.

6. www.fda.gov › media › 167212FACT SHEET FOR RECIPIENTS AND CAREGIVERS ABOUT PFIZER-BIONTECH...

   www.fda.gov › media › 167212

   22 sie 2024 · COMIRNATY is an FDA-approved vaccine for prevention of COVID-19 in individuals 12 years of age and older that is authorized under EUA to complete the dosing schedule for immunocompromised...

7. www.cdc.gov › vaccines › phpPfizer COVID-19 Vaccine Summary | Vaccines & Immunizations | CDC

   www.cdc.gov › vaccines › php

   • Zapisane w pamięci cache

   28 sie 2024 · Pfizer-BioNTech COVID-19 Vaccine is indicated for individuals 5 through 11 years of age (via a 10mcg / 0.3mL single-dose vial presentation) and for individuals 6 months through 4 years of age (via a 3mcg / 0.3mL multi-dose vial (3 doses per vial) presentation).